What Does the Historical and Current Rat Model Market Size Trend Indicate?
The rat model market has seen considerable growth due to a variety of factors.
•The market for rat models has exhibited significant growth in the past few years and is projected to further increase from $1.65 billion in 2024 to $1.77 billion in 2025, with a compound annual growth rate (CAGR) of 7.4%.
This growth during the historic period is due to the escalating demand for preclinical research, enhanced government funding, an increase in research demand, initiatives in drug development, and an upward trend in chronic diseases.
How Will the Rat Model Market Size Evolve over the Forecast Period?
The rat model market is expected to maintain its strong growth trajectory in upcoming years.
• In the upcoming years, the rat model market is predicted to experience robust expansion, reaching a size of $2.56 billion in 2029, with a compound annual growth rate (CAGR) of 9.8%.
This surge during the forecast period is linked to the broadening applications in personalised medicine, the increasing demand for animal models in drug discovery, a heightened emphasis on disease prevention, the proliferation of the biopharmaceutical sector, advancements in imaging techniques, and financial support from both government and private entities. Key trends during this period comprise worldwide research collaborations, technological evolution in imaging, the incorporation of omics technologies, progress in genome editing methods, the escalating significance of rat models in disease research, and the advent of personalised medicine and bespoke rat models.
What Factors Are Driving Growth In The Rat Model Market?
The upward trend of chronic diseases is anticipated to propel the rat model market's expansion. These conditions, that persist for over a year, interfere with daily routines, necessitate sustained medical attention, or both, are referred to as chronic diseases. Rat models serve a crucial role in investigating the origin, immune reactions, and healing of persistent infections, offering crucial understanding that aids the creation of innovative treatments and strategies. For example, the World Health Organization, a Switzerland-based United Nations specialized agency, reported in September 2023 that 41 million deaths accounted for 74% of all deaths caused by non-communicable diseases (NCDs) or chronic diseases globally each year. Hence, the escalating prevalence of chronic diseases is steering the growth of the rat model market.
What Are The Main Segments Of The Global Rat Model Market?
The rat model market covered in this report is segmented –
1) By Type: Knockout, Outbred, Inbred, Hybrid, Immunodeficient, Conditioned
2) By Service: Cryopreservation, Breeding, Re-derivation, Genetic Testing, Quarantine Depending, Other Services
3) By Technology: Nuclear Transferase, Microinjection, Embryonic Stem Cell, Other Technologies
4) By Application: Oncology, Neurology, Immunology, Toxicology, Other Applications
Subsegments:
1) By Knockout: CRISPR Knockout, Traditional Knockout
2) By Outbred: Sprague Dawley, Long-Evans, Wistar
3) By Inbred: Fischer 344, Lewis, Buffalo
4) By Hybrid: F1 Hybrid, F2 Hybrid
5) By Immunodeficient: Nude Rats, SCID Rats
6) By Conditioned: Obese Rats, Diabetic Rats
Pre-Book The Rat Model Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Emerging Trends Are Influencing The Growth Of The Rat Model Market?
Key players in the rat model market are establishing strategic alliances for preclinical studies in oncology and other therapeutic domains. These collaborations allow them to concentrate on their main business while taking advantage of the effectiveness and affordability provided by specialized rat model providers that possess the necessary infrastructure and resources to produce rat models. For example, in March 2022, a strategic partnership was formed between Hera BioLabs, a biotechnology firm based in the US, and Charles River Laboratories International Inc., a pharmaceutical company also based in the US, for the commercialization of Hera's SRG rat, also referred to as OncoRat. As part of this agreement, Charles River will breed, distribute, market, and sell the SRG rat directly to the preclinical research community. The SRG rat, a highly immunodeficient type of rat, is particularly well-suited for xenograft or PDX studies, offering unique benefits compared to mouse models for the in vivo effectiveness evaluation of prospective cancer treatments. This model overcomes the constraints of smaller mouse models by allowing for increased tumor growth, simpler surgeries, and more tissue and serum for analysis, including repeat sampling.
Who Are the Key Players in the Rat Model Market?
Major companies operating in the rat model market include:
• Genoway S.A.
• Biomere
• Transposagen Biopharmaceuticals Inc.
• Horizon Discovery Group PLC
• Transviragen Inc.
• Charles River Laboratories International Inc.
• Taconic Biosciences Inc.
• Envigo Ltd.
• Laboratory Corporation of America Holdings
• Janvier Labs
• Harlan Laboratories Inc.
• Sage Path Labs
• Applied StemCell Inc.
• Regenera Pharma Ltd.
• Cyagen Biosciences Inc.
• Ozgene Pty Ltd
• Yecuris Corporation
• Hera BioLabs Inc.
• Beijing Biocytogen Co. Ltd.
• Ingenious Targeting Laboratory
• InVivos Pte Ltd.
• Kymab Limited
• Mirimus Inc.
• Pharmaron Beijing Co. Ltd.
• PolyGene AG
• Shanghai Model Organisms Center Inc.
• Sino Biological Inc.
• Synthego Corporation
• Transgenic Inc.
• ViGene Biosciences Inc.
• Viva Biotech Holdings
• WuXi AppTec Co. Ltd.
What Is The Most Dominant Region In The Rat Model Market?
North America was the largest region in the rat model market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global rat model market report during the forecast period. The regions covered in the rat model market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
